These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 2294105)
1. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. Hogg PJ; Jackson CM J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105 [TBL] [Abstract][Full Text] [Related]
2. Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex. Hogg PJ; Jackson CM J Biol Chem; 1990 Jan; 265(1):241-7. PubMed ID: 2294104 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation. Hotchkiss KA; Chesterman CN; Hogg PJ Blood; 1994 Jul; 84(2):498-503. PubMed ID: 8025278 [TBL] [Abstract][Full Text] [Related]
4. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen. Hogg PJ; Jackson CM; Labanowski JK; Bock PE J Biol Chem; 1996 Oct; 271(42):26088-95. PubMed ID: 8824251 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. Lewis SD; Shields PP; Shafer JA J Biol Chem; 1985 Aug; 260(18):10192-9. PubMed ID: 4019507 [TBL] [Abstract][Full Text] [Related]
6. Release of fibrinopeptides by the slow and fast forms of thrombin. Vindigni A; Di Cera E Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191 [TBL] [Abstract][Full Text] [Related]
7. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain. Odrljin TM; Shainoff JR; Lawrence SO; Simpson-Haidaris PJ Blood; 1996 Sep; 88(6):2050-61. PubMed ID: 8822924 [TBL] [Abstract][Full Text] [Related]
8. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. Higgins DL; Lewis SD; Shafer JA J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg. Furlan M; Rupp C; Beck EA Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of fibrin-bound thrombin by a covalent antithrombin-heparin complex. Berry LR; Becker DL; Chan AK J Biochem; 2002 Aug; 132(2):167-76. PubMed ID: 12153711 [TBL] [Abstract][Full Text] [Related]
11. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors. Weitz JI; Leslie B; Hudoba M Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024 [TBL] [Abstract][Full Text] [Related]
12. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Hogg PJ; Jackson CM Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739 [TBL] [Abstract][Full Text] [Related]
13. Evidence for multiple enzyme site involvement in the modulation of thrombin activity by products of prothrombin proteolysis. Shi F; Hogg PJ; Winzor DJ; Jackson CM Biophys Chem; 1998 Dec; 75(3):187-99. PubMed ID: 9894338 [TBL] [Abstract][Full Text] [Related]
14. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects. De Cristofaro R; Landolfi R Thromb Haemost; 2000 Feb; 83(2):253-61. PubMed ID: 10739383 [TBL] [Abstract][Full Text] [Related]
15. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin]. Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798 [TBL] [Abstract][Full Text] [Related]
16. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818 [TBL] [Abstract][Full Text] [Related]
17. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. Weisel JW; Veklich Y; Gorkun O J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664 [TBL] [Abstract][Full Text] [Related]
18. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B. Dyr JE; Blombäck B; Hessel B; Kornalík F Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147 [TBL] [Abstract][Full Text] [Related]
19. Effects of protons on the thrombin-fibrinogen interaction. Picozzi M; Landolfi R; De Cristofaro R Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314 [TBL] [Abstract][Full Text] [Related]
20. Thrombin-fibrinogen interaction: pH dependence and effects of the slow-->fast transition. Mathur A; Schlapkohl WA; Di Cera E Biochemistry; 1993 Jul; 32(29):7568-73. PubMed ID: 8393345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]